Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor

NCT02069158 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
NSCLC
Ovary Cancer
Endometrial Cancer
Small Cell Lung Cancer (SCLC)
Head and Neck (HNSCC)

Interventions

DRUG: PF-05212384
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Cristiana Sessa